Astria Therapeutics Statistics
Total Valuation
ATXS has a market cap or net worth of $704.43 million. The enterprise value is $481.16 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ATXS has 57.08 million shares outstanding. The number of shares has increased by 14.24% in one year.
| Current Share Class | 57.08M |
| Shares Outstanding | 57.08M |
| Shares Change (YoY) | +14.24% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.48% |
| Owned by Institutions (%) | 55.74% |
| Float | 42.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 997.77 |
| Forward PS | 115.10 |
| PB Ratio | 5.05 |
| P/TBV Ratio | 5.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 681.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.78, with a Debt / Equity ratio of 0.02.
| Current Ratio | 10.78 |
| Quick Ratio | 10.42 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.15% and return on invested capital (ROIC) is -29.17%.
| Return on Equity (ROE) | -43.15% |
| Return on Assets (ROA) | -26.94% |
| Return on Invested Capital (ROIC) | -29.17% |
| Return on Capital Employed (ROCE) | -54.97% |
| Revenue Per Employee | $9,051 |
| Profits Per Employee | -$1.59M |
| Employee Count | 78 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.88% in the last 52 weeks. The beta is 0.08, so ATXS's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | +27.88% |
| 50-Day Moving Average | 10.57 |
| 200-Day Moving Average | 7.04 |
| Relative Strength Index (RSI) | 61.39 |
| Average Volume (20 Days) | 1,047,421 |
Short Selling Information
The latest short interest is 3.14 million, so 5.51% of the outstanding shares have been sold short.
| Short Interest | 3.14M |
| Short Previous Month | 4.02M |
| Short % of Shares Out | 5.51% |
| Short % of Float | 7.47% |
| Short Ratio (days to cover) | 0.89 |
Income Statement
In the last 12 months, ATXS had revenue of $706,000 and -$124.03 million in losses. Loss per share was -$2.14.
| Revenue | 706,000 |
| Gross Profit | 706,000 |
| Operating Income | -136.51M |
| Pretax Income | -124.03M |
| Net Income | -124.03M |
| EBITDA | n/a |
| EBIT | -136.51M |
| Loss Per Share | -$2.14 |
Full Income StatementBalance Sheet
The company has $227.72 million in cash and $4.46 million in debt, giving a net cash position of $223.26 million or $3.91 per share.
| Cash & Cash Equivalents | 227.72M |
| Total Debt | 4.46M |
| Net Cash | 223.26M |
| Net Cash Per Share | $3.91 |
| Equity (Book Value) | 233.25M |
| Book Value Per Share | 2.44 |
| Working Capital | 230.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$119.73 million and capital expenditures -$590,000, giving a free cash flow of -$120.32 million.
| Operating Cash Flow | -119.73M |
| Capital Expenditures | -590,000 |
| Free Cash Flow | -120.32M |
| FCF Per Share | -$2.11 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -19,335.69% |
| Pretax Margin | -17,567.99% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATXS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.24% |
| Shareholder Yield | -14.24% |
| Earnings Yield | -17.61% |
| FCF Yield | -17.08% |
Analyst Forecast
The average price target for ATXS is $24.33, which is 97.16% higher than the current price. The consensus rating is "Hold".
| Price Target | $24.33 |
| Price Target Difference | 97.16% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -13.22% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 20, 2021. It was a reverse split with a ratio of 1:6.
| Last Split Date | Aug 20, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
ATXS has an Altman Z-Score of 1.81 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 1 |
